These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3382163)

  • 1. [New therapy for Peyronie's disease: superoxide dismutase by ionization. Comparison with an earlier classical series].
    Vergès J; Chateau A
    Ann Urol (Paris); 1988; 22(2):143-4. PubMed ID: 3382163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iontophoresis with Thiomucase. A new treatment for induratic penis plastics].
    Arrigoni G; Pagano S
    J Urol Nephrol (Paris); 1976; 82(7-8):695. PubMed ID: 137326
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iontophoresis in Peyronie's disease. Our experience].
    Pérez Espejo Mde L; Campoy Martínez P; Pérez Pérez M; Argüelles Salido E; Rodríguez Pérez A; Soltero González A
    Arch Esp Urol; 2003 Dec; 56(10):1133-7. PubMed ID: 14763419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.
    Riedl CR; Sternig P; Gallé G; Langmann F; Vcelar B; Vorauer K; Wagner A; Katinger H; Pflüger H
    Eur Urol; 2005 Oct; 48(4):656-61. PubMed ID: 15982798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoresis for treatment of Peyronie's disease.
    Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
    J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personal results of treatment in penile induration (Peyronie's disease) and some remarks on pertinent therapeutic problems].
    Chojna JW
    Pol Przegl Chir; 1971 Oct; 43(10):1611-6. PubMed ID: 5137430
    [No Abstract]   [Full Text] [Related]  

  • 8. Orgotein, a new drug for the treatment of Peyronie's disease.
    Bartsch G; Menander-Huber KB; Huber W; Marberger H
    Eur J Rheumatol Inflamm; 1981; 4(2):250-9. PubMed ID: 7044791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ultrasonic treatment of Peyronie's disease.
    Frank IN; Scott WW
    J Urol; 1971 Dec; 106(6):83-7. PubMed ID: 5116297
    [No Abstract]   [Full Text] [Related]  

  • 10. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
    Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
    J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orgotein in the treatment of plastic induration of the penis (Peyronie's disease).
    Primus G
    Int Urol Nephrol; 1993; 25(2):169-72. PubMed ID: 8365848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative treatment for Peyronie's disease: an update.
    El-Sakka AI; Yassin AA
    Expert Opin Pharmacother; 2008 Jan; 9(1):53-63. PubMed ID: 18076338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The therapy of plastic penile induration using superoxide dismutase per os and injection combined with vasoactive intracavernous pharmacotherapy].
    Pastorini S; Marino G; Brigato R; Griffa D; Cocimano V
    Minerva Urol Nefrol; 1991; 43(2):75-8. PubMed ID: 1957233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of the ultrasounds in the Peyronie's disease (author's transl)].
    Ginsberg F; Weiser M; Famaey JP
    J Belge Med Phys Rehabil; 1978; 1(1):57-64. PubMed ID: 757417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peyronie's disease. Therapeutic difficulties].
    Guillé F; Nguyen Hoang T; Dufeuil P; Lobel B
    Ann Urol (Paris); 1988; 22(1):65-6. PubMed ID: 3369849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial.
    Chitale S; Morsey M; Swift L; Sethia K
    BJU Int; 2010 Nov; 106(9):1352-6. PubMed ID: 20438568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study on liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease.
    Riedl CR; Plas E; Vorauer K; Vcelar B; Wagner A; Pflüger H
    Eur Urol; 2001 Sep; 40(3):343-8; discussion 348-9. PubMed ID: 11684853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Propoleum and Peyronie's disease].
    Lemourt Oliva M; Rodríguez Barroso A; Puente Guillén M; Vega Guerrero C; Navarro Cutiño M; Pérez Monzón A
    Arch Esp Urol; 2003 Sep; 56(7):805-13. PubMed ID: 14595885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.